MedPath

TD POLIO ADSORBED

TD POLIO ADSORBED

Discontinued
DIN Number

00615358

Drug Class

Human

Market Date

Dec 31, 1984

Company
HC

Sanofi Pasteur Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00615358
AIG Number0528062002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07CA01 DIPHTHERIA-POLIOMYELITIS-TETANUS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:08.00
Health Canada Classification

ACTIVE INGREDIENTS (5)

DIPHTHERIA TOXOIDActive
Strength: 2 LF / 0.5 ML
Monograph: DIPHTHERIA TOXOID
INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEYActive
Strength: 40 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY
INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1Active
Strength: 8 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1
INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETTActive
Strength: 32 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT
TETANUS TOXOIDActive
Strength: 5 LF / 0.5 ML
Monograph: TETANUS TOXOID

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.